Literature DB >> 12949408

Vesicular stomatitis virus infection and neuropathogenesis in the murine model are associated with apoptosis.

J-H Sur1, R Allende, A R Doster.   

Abstract

This study examines apoptosis and viral neuropathogenesis in a murine model infected with vesicular stomatitis virus (VSV). VSV induces apoptotic cell death in cultured cell lines, raising the possibility that apoptosis of infected neurons and other target cells may contribute to disease and mortality. To determine whether or not VSV induces apoptosis in neural tissues, mice were inoculated intranasally with VSV. At 24, 48, 72, 96, and 120 hours postinfection, brain tissues were assayed for the presence of viral RNA by in situ hybridization and viral antigen by immunohistochemistry. Apoptosis was identified by in situ terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling and electron microscopy. Viral replication and lesions were observed predominantly in central nervous system neurons. Apoptotic cell death was restricted to the same regions of the brain in which infected cells and tissue injury were identified. Results suggest that VSV-induced apoptosis is a mechanism causing cell death, tissue injury, and mortality in VSV-infected mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949408     DOI: 10.1354/vp.40-5-512

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  10 in total

1.  Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus.

Authors:  Tomasz Tomczyk; Grażyna Wróbel; Radosław Chaber; Iwona Siemieniec; Egbert Piasecki; Małgorzata Krzystek-Korpacka; Beata U Orzechowska
Journal:  J Innate Immun       Date:  2018-01-06       Impact factor: 7.349

2.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  hsp70-dependent antiviral immunity against cytopathic neuronal infection by vesicular stomatitis virus.

Authors:  Mi Young Kim; Yuanmei Ma; Yu Zhang; Jianrong Li; Yaoling Shu; Michael Oglesbee
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

4.  Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.

Authors:  Chad E Mire; Andrew D Miller; Angela Carville; Susan V Westmoreland; Joan B Geisbert; Keith G Mansfield; Heinz Feldmann; Lisa E Hensley; Thomas W Geisbert
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

5.  Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

Authors:  J Erik Johnson; Farooq Nasar; John W Coleman; Roger E Price; Ali Javadian; Kenneth Draper; Margaret Lee; Patricia A Reilly; David K Clarke; R Michael Hendry; Stephen A Udem
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

6.  Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.

Authors:  Lukxmi Balathasan; Vera A Tang; Beta Yadollahi; Jan Brun; Melanie Labelle; Charles Lefebvre; Stephanie L Swift; David F Stojdl
Journal:  Mol Ther Oncolytics       Date:  2017-09-15       Impact factor: 7.200

7.  Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression.

Authors:  Emily A Gomme; Christoph Wirblich; Sankar Addya; Glenn F Rall; Matthias J Schnell
Journal:  PLoS Pathog       Date:  2012-10-11       Impact factor: 6.823

8.  Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer.

Authors:  Wei Shi; Qingqing Tang; Xiancheng Chen; Ping Cheng; Peidu Jiang; Xiaomei Jing; Xiang Chen; Ping Chen; Yongsheng Wang; Yuquan Wei; Yanjun Wen
Journal:  J Mol Med (Berl)       Date:  2009-03-04       Impact factor: 5.606

9.  In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion.

Authors:  Phonphimon Wongthida; Juggragarn Jengarn; Jaraspim Narkpuk; Pongpisid Koonyosying; Kanjana Srisutthisamphan; Asawin Wanitchang; Pornsawan Leaungwutiwong; Samaporn Teeravechyan; Anan Jongkaewwattana
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

Review 10.  Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy.

Authors:  Boris Simovic; Scott R Walsh; Yonghong Wan
Journal:  Oncolytic Virother       Date:  2015-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.